Quantitative Investment Management’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-262,429
| Closed | -$26.1M | – | 851 |
|
|
2019
Q3 | $26.1M | Buy |
+262,429
| New | +$24.9M | 1.39% | 6 |
|
|
2019
Q1 | – | Sell |
-32,300
| Closed | -$2.07M | – | 920 |
|
|
2018
Q4 | $2.07M | Buy |
+32,300
| New | +$2.38M | 0.11% | 184 |
|
|
2017
Q4 | – | Sell |
-322,900
| Closed | -$47.1M | – | 952 |
|
|
2017
Q3 | $47.1M | Sell |
322,900
-163,900
| -34% | -$22.3M | 0.54% | 31 |
|
|
2017
Q2 | $63.2M | Buy |
486,800
+429,700
| +753% | +$52.7M | 0.95% | 10 |
|
|
2017
Q1 | $7.1M | Buy |
+57,100
| New | +$6.83M | 0.11% | 260 |
|
|
2016
Q2 | – | Sell |
-7,700
| Closed | -$770K | – | 1053 |
|
|
2016
Q1 | $770K | Sell |
7,700
-37,300
| -83% | -$3.84M | 0.04% | 458 |
|
|
2015
Q4 | $5.39M | Buy |
+45,000
| New | +$5.21M | 0.33% | 69 |
|
|
2015
Q3 | – | Sell |
-36,400
| Closed | -$4.21M | – | 872 |
|
|
2015
Q2 | $4.21M | Buy |
+36,400
| New | +$4.16M | 0.63% | 34 |
|
|
2015
Q1 | – | Sell |
-33,200
| Closed | -$3.71M | – | 833 |
|
|
2014
Q4 | $3.71M | Buy |
+33,200
| New | +$3.5M | 0.57% | 37 |
|
|
2014
Q3 | – | Sell |
-10,800
| Closed | -$927K | – | 628 |
|
|
2014
Q2 | $927K | Buy |
+10,800
| New | +$821K | 0.17% | 125 |
|
|
2013
Q4 | – | Sell |
-24,000
| Closed | -$1.85M | – | 817 |
|
|
2013
Q3 | $1.85M | Buy |
24,000
+2,000
| +9% | +$140K | 0.16% | 126 |
|
|
2013
Q2 | $1.29M | Buy |
+22,000
| New | +$1.32M | 0.23% | 98 |
|
Other funds holding CELG
Quantitative Investment Management's CELG Position: Q4 2019 in Review
Quantitative Investment Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 262,429 shares — an estimated $26.1M sold.
Quantitative Investment Management first reported a position in CELG in Q2 2013 and held it in 12 quarters. The position peaked at $63.2M in Q2 2017. 3 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Quantitative Investment Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Quantitative Investment Management sold 262,429 Celgene Corp shares in Q4 2019, an estimated $26.1M.
- Quantitative Investment Management first reported a position in Celgene Corp in Q2 2013 and held it in 12 quarters.
- Quantitative Investment Management's Celgene Corp position peaked at $63.2M in Q2 2017.
- 3 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Quantitative Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.